FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/10/058319 [Registered on: 05/10/2023] Trial Registered Prospectively
Last Modified On: 27/09/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Treatment]  
Study Design  Single Arm Study 
Public Title of Study   Clinical trial of Pathya Amalakadi Decoction in management of Leucorrhoea. 
Scientific Title of Study   Clinical trial of Pathya Amalakadi Kashaya in management of Shweta Pradara (Leucorrhoea). 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr L Venkata Rathnakar 
Designation  Professor 
Affiliation  Sri Jayendra Saraswathi Ayurveda College and Hospital 
Address  Room no 13, Department of Prasuti Tantra and Stree Roga, Shree Jayendra Saraswathi Ayurveda College and Hospital, Nazarathpettai, Chennai- 600123

Thiruvallur
TAMIL NADU
600123
India 
Phone  9840340826  
Fax    
Email  drlrathnakar@sjsach.org.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr L Venkata Rathnakar 
Designation  Professor 
Affiliation  Sri Jayendra Saraswathi Ayurveda College and Hospital 
Address  Room no 13, Department of Prasuti Tantra and Stree Roga, Shree Jayendra Saraswathi Ayurveda College and Hospital, Nazarathpettai, Chennai- 600123

Thiruvallur
TAMIL NADU
600123
India 
Phone  9840340826  
Fax    
Email  drlrathnakar@sjsach.org.in  
 
Details of Contact Person
Public Query
 
Name  Dr Priyanka Balaram Kamble 
Designation  P.G. Scholar 
Affiliation  Sri Jayendra Saraswathi Ayurveda College and Hospital 
Address  Room no 13, Department of Prasuti Tantra and Stree Roga, Shree Jayendra Saraswathi Ayurveda College and Hospital, Nazarathpettai, Chennai- 600123

Thiruvallur
TAMIL NADU
600123
India 
Phone  9137304446  
Fax    
Email  kamblepriyanka659@gmail.com  
 
Source of Monetary or Material Support  
Sri Jayendra Saraswathi Ayurveda College and Hospital, Prasuti Tantra and Stree Roga Outpatient Department, Nazarathpettai, Chennai- 600123 
 
Primary Sponsor  
Name  Dr Priyanka Balaram Kamble 
Address  Room no 13, Department of Prasuti Tantra and Stree Roga, Sri Jayendra Saraswathi Ayurveda College and Hospital, Nazarathpettai, Chennai- 600123 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Priyanka Kamble  Sri Jayendra Saraswathi Ayurveda College and Hospital   Room no 13, Department of PTSR, Sri Jayendra Saraswathi Ayurveda College and Hospital, Nazarathpeth, Chennai 600123
Thiruvallur
TAMIL NADU 
9137304446

kamblepriyanka659@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee of Sri Jayendra Saraswathi Ayurveda College and Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N898||Other specified noninflammatory disorders of vagina. Ayurveda Condition: SOMAROGAH/SVETAPRADARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Pathya Amalakadi Kashaya , Reference: Sahasrayoga Kashaya Yoga Prakaran, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 25(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: Madhu), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Female 
Details  Patient having clinical features of Shweta Pradara.
Patient complaining of vaginal discharge as the cardinal symptom.

 
 
ExclusionCriteria 
Details  Unmarried women.
Pregnant women. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief in white discharge of Shweta Pradara.  30 Days 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   10/10/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="30" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Shweta Pradara is a condition in which there is a whitish discharge from the vagina. The study titled ’Clinical trial of Pathya Amalakadi Kashaya in management of Shweta Pradara (Leucorrhoea)’ is a single-arm open-label observational clinical trial in which 40 married female patients from 18 yrs to 50 yrs having clinical features of Shweta Pradara and complaining of vaginal discharge as the cardinal symptom will be selected for the study excluding pregnant woemen. The patients will be tested for urine routine and microscopic and vaginal wet smear before the study. Later, they will be administered Pathya Amalakadi Kashaya 50 mL twice daily half an hour before food in lukewarm stage with 10 mL of Madhu as the Prakshepa Dravya for 30 days. After completion of course, patients will be advised to report 15 days after completion of the medicine course. Three follow-ups will be conducted with a gap of 15 days between each follow-up. We will evaluate the efficacy of the selected drug on Shweta Pradara (Leucorrhoea). The primary outcome will be to assess the improvement in the patient mainly on the basis of relief in the signs and symptoms of the disease. Further recurrence in the signs & symptoms will be recorded during the follow-up study.

 


 
Close